Bioactive Compounds in Moringa oleifera: Mechanisms of Action, Focus on Their Anti-Inflammatory Properties
- PMID: 38202328
- PMCID: PMC10780634
- DOI: 10.3390/plants13010020
Bioactive Compounds in Moringa oleifera: Mechanisms of Action, Focus on Their Anti-Inflammatory Properties
Abstract
Moringa oleifera (M. oleifera) is a tropical tree native to Pakistan, India, Bangladesh, and Afghanistan; it is cultivated for its nutritious leaves, pods, and seeds. This scientific study was conducted to outline the anti-inflammatory properties and mechanisms of action of bioactive compounds from M. oleifera. The existing research has found that the plant is used in traditional medicine due to its bioactive compounds, including phytochemicals: flavonoids and polyphenols. The compounds are thought to exert their anti-inflammatory effects due to: (1) inhibition of pro-inflammatory enzymes: quercetin and kaempferol inhibit the pro-inflammatory enzymes (cyclooxygenase and lipoxygenase); (2) regulation of cytokine production: isothiocyanates modulate signaling pathways involved in inflammation, such as the nuclear factor-kappa B (NF-kappa B) pathway; isothiocyanates inhibit the production of pro-inflammatory cytokines such as TNF-α (tumor necrosis factor α) and IL-1β (interleukin-1β); and (3) antioxidant activity: M. oleifera contains flavonoids, polyphenols, known to reduce oxidative stress and inflammation. The review includes M. oleifera's effects on cardiovascular protection, anti-hypertensive activities, type 2 diabetes, inflammatory bowel disease, and non-alcoholic fatty liver disease (NAFLD). This research could prove valuable for exploring the pharmacological potential of M. oleifera and contributing to the prospects of developing effective medicines for the benefit of human health.
Keywords: Moringa oleifera; NAFLD; anti-inflammatory activity; anti-oxidative stress; chronic inflammatory diseases; kaempferol; nuclear factor-kappa B; polyphenols; quercetin; type 2 diabetes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







References
-
- Ezzat S.M., Jeevanandam J., Egbuna C., Kumar S., Ifemeje J.C. Phytochemicals as Sources of Drugs. In: Kumar S., Egbuna C., editors. Phytochemistry: An In-Silico and In-Vitro Update. Springer; Singapore: 2019. pp. 3–22.
-
- Kuete V. Moringa oleifera. In: Kuete V., editor. Medicinal Spices and Vegetables from Africa. Elsevier; Amsterdam, The Netherlands: 2017. pp. 485–496.
-
- Noubissi P.A., Njilifac Q., Tagne M.A.F., Nguepi M.S.D., Fondjo A.F., Emégam N.K., Mukam J.N., Zintchem R., Wambe H., Fankem G.O., et al. Anxiolytic and anti-colitis effects of Moringa oleifera leaf-aqueous extract on acetic acid-induced colon inflammation in rat. Biomed. Pharmacother. 2022;154:113652. doi: 10.1016/j.biopha.2022.113652. - DOI - PubMed
-
- Foidl N., Makkar H., Becker K. The Potential of Moringa oleifera for agricultural and industrial uses. In: Fuglie L.J., editor. The Miracle Tree: The Multiple Attributes of Moringa. CTA; Wageningen, The Netherlands: CWS; Dakar, Senegal: 2001. pp. 45–76.
Publication types
LinkOut - more resources
Full Text Sources